Public Health – Page 10

Impact of a $40 Monthly Healthy Food Benefit on Food Security and Fruit and Vegetable Intake in Lower-Income Populations

By MedXY 09/11/2025

A cohort study found that a $40 monthly healthy food benefit program significantly improved food security and increased the frequency of fruit and vegetable consumption among lower-income urban adults, highlighting its potential to reduce nutrition-related health disparities.

Emergency Medicine Infectious Diseases Public Health Specialties

Optimizing Hepatitis C Screening in Emergency Departments: Insights from the DETECT Hep C Randomized Clinical Trial

By MedXY 09/11/2025

The DETECT Hep C trial demonstrates nontargeted HCV screening in emergency departments identifies more new infections than risk-based approaches, though linkage to care remains suboptimal, underscoring the need for innovative treatment models.

Clinical Updates news Public Health Specialties

The Dawn of the “No-Clinical-Trial” Era for Biosimilars: FDA’s Historic Ustekinumab Approval Shift

By MedXY 09/06/2025

The US FDA's unprecedented exemption of clinical efficacy studies for a ustekinumab biosimilar marks a transformative regulatory milestone, reshaping biosimilar development, market dynamics, and patient access worldwide.

Clinical Updates Internal Medicine news Public Health Respiratory Specialties

High-Dose vs Standard-Dose Influenza Vaccine in Older Adults: Insights from the DANFLU-2 Randomized Clinical Trial

By MedXY 09/06/2025

The DANFLU-2 trial demonstrates that high-dose influenza vaccine reduces cardiovascular and cardiorespiratory hospitalizations compared to standard-dose in adults ≥65 years, with similar benefits across subgroups including heart failure and atherosclerotic cardiovascular disease.

Cardiology Public Health Specialties

Enhanced Protection in Heart Failure: High-Dose Influenza Vaccine Outperforms Standard Dose in the DANFLU-2 Trial

By MedXY 09/06/2025

The DANFLU-2 trial reveals that high-dose influenza vaccine significantly reduces hospitalization for influenza and cardiovascular events in older adults, including those with heart failure, compared to the standard-dose vaccine.

Cardiology Clinical Updates Public Health Specialties

PANDA II Trial Confirms Influenza Vaccination as Essential Intervention for Acute Heart Failure Patients

By MedXY 09/03/2025

The PANDA II study demonstrates that influenza vaccination significantly reduces mortality and rehospitalization in acute heart failure patients, supporting its inclusion as a standard component of heart failure management worldwide.

Infectious Diseases Public Health Specialties

Azelastine Nasal Spray Significantly Reduces SARS-CoV-2 Infection Risk: Results from a Phase 2 Randomized Clinical Trial

By MedXY 09/02/2025

This phase 2 trial demonstrates that azelastine nasal spray reduces SARS-CoV-2 infections and symptomatic respiratory illnesses in a healthy, vaccinated adult population, suggesting its potential as a safe, scalable prophylactic measure against COVID-19.

Clinical Updates Infectious Diseases news Public Health Specialties

Evaluating RSV Vaccine Effectiveness Against Hospitalization in US Adults Aged 60 and Older Over Two Seasons

By MedXY 09/01/2025

A large multicenter study demonstrates that a single dose of RSV vaccine reduces hospitalization risk by 58% among adults aged 60+, with lower effectiveness in immunocompromised and cardiovascular patients.

Cardiology news Public Health Respiratory Specialties

Bivalent RSV Prefusion F Protein Vaccine: A Potential Strategy to Reduce Cardiovascular Hospitalizations in Older Adults

By MedXY 09/01/2025

The DAN-RSV trial demonstrates that RSV vaccination significantly lowers all-cause cardiorespiratory hospitalizations among older adults, suggesting vaccines may reduce infection-triggered cardiovascular complications and benefit chronic disease management.

Family Medicine & Nutrition Medical News Public Health Specialties

Invisible Invaders: How Microplastics Penetrate Our Bodies and What You Can Do About It

By MedXY 09/01/2025

Microplastics, tiny plastic particles under 5mm, have silently infiltrated our bodies through drinking water, air, and food. They accumulate in organs, accelerate cell aging, and increase inflammation. Learn hidden sources and practical tips to reduce exposure.

Family Medicine & Nutrition news Public Health Specialties

Invisible Intruders: Microplastics Found in Every Human Placenta Sample Tested

By MedXY 08/31/2025

Recent research shows microplastics present in 100% of 62 human placentas analyzed, raising concerns about prenatal exposure and future health implications.

Family Medicine & Nutrition Medical News news Public Health Specialties

Microwaving Plastic Containers: A Hidden Source of Billions of Microplastic Particles in Your Food

By MedXY 08/31/2025

Recent research reveals that microwaving plastic food containers can release billions of micro- and nanoplastic particles into food, posing potential health risks, especially to infants and young children. Understanding this silent contamination is vital for safer food practices.

Public Health Specialties

FDA Approves Updated COVID-19 Vaccines Targeting Latest LP.8.1 Variant for High-Risk and Older Adults

By MedXY 08/31/2025

The FDA has authorized updated COVID-19 vaccines from Pfizer and Moderna designed to target the LP.8.1 sublineage, expanding vaccination to adults over 65 and individuals with high-risk conditions, enhancing immune defense against evolving variants.

Medical News news Oncology Public Health Specialties

Persistent Medical Debt After Cancer Diagnosis: Insights from a Large Massachusetts Cohort Study

By MedXY 08/30/2025

A Massachusetts cohort study reveals modest but persistent increases in medical debt after cancer diagnosis, particularly in colorectal and bladder cancers, despite high insurance coverage. Total debt, bankruptcy rates, and credit scores remained largely unchanged in the overall population.

Cardiology Public Health Specialties

High-Dose Influenza Vaccines Cut Hospitalizations: Landmark Trials Shape Cardiovascular Prevention

By MedXY 08/30/2025

Two massive randomized trials show high-dose flu vaccines reduce influenza-related and cardiorespiratory hospitalizations in older adults, reinforcing vaccination as a vital cardiovascular prevention strategy.

Family Medicine & Nutrition Gastroenterology Psychiatry Public Health Specialties

Unraveling Chronic Stress: The Role of Gut Dysbiosis and Vitamin B6 Metabolism in Stress-Related Brain Disorders Independent of Cortisol

By MedXY 08/30/2025

Recent evidence reveals gut dysbiosis-induced vitamin B6 metabolic disturbances as a novel, cortisol-independent mechanism driving chronic stress-related abnormal behaviors and inflammation, highlighting probiotic and vitamin B6 supplementation as potential therapeutic strategies.

Emergency Medicine Infectious Diseases news Pediatrics Public Health Specialties

Enhancing Early Risk Stratification of Severe Childhood Febrile Illness in Rural Asia Using sTREM1 Biomarker

By MedXY 08/30/2025

A multicountry study across Asia demonstrates soluble TREM1's superior accuracy over traditional clinical signs in predicting severe febrile illness in children, potentially transforming triage in resource-limited settings.

Cardiology Public Health Respiratory Specialties

Ventilation Hoods During Cooking Significantly Reduce PM2.5 Exposure and Improve Cardiometabolic and Pulmonary Health: Evidence from a Cluster-Randomized Trial in Rural China

By MedXY 08/30/2025

A community-based intervention using ventilation hoods during cooking reduced 24-hour PM2.5 exposure by nearly 30% and improved cardiometabolic and pulmonary health markers in rural Chinese villages reliant on wood fuel.

Pediatrics Public Health Specialties

Promising Immunogenicity and Safety of the Live-Attenuated Intranasal RSV Vaccine in Infants and Toddlers

By MedXY 08/28/2025

This phase I/II trial demonstrates that the live-attenuated intranasal RSV vaccine (RSVt) is immunogenic and well-tolerated in infants and toddlers, offering a potential new preventive option against RSV infection.

Public Health Specialties

Evaluating Community-Wide Mass Drug Administration to Interrupt Soil-Transmitted Helminth Transmission: Insights from the DeWorm3 Trial

By MedXY 08/27/2025

The DeWorm3 trial assessed whether high-coverage community-wide mass drug administration with albendazole could interrupt soil-transmitted helminth transmission in Benin, India, and Malawi but found limited success, suggesting tailored approaches are needed.